Death induced by survival gene elimination (DISE) contributes to neurotoxicity in Alzheimer's disease

Alzheimer’s disease (AD) is characterized by progressive neurodegeneration, but the specific events that cause cell death remain poorly understood. Death Induced by Survival gene Elimination (DISE) is a recently discovered powerful cell death mechanism mediated by short (s) RNAs including micro (mi) RNAs acting through the RNA induced silencing complex (RISC). G-rich 6mer seed sequences in the sRNAs (position 2-7) target hundreds of C-rich seed matches in genes essential for cell survival resulting in the simultaneous activation of multiple cell death pathways. Using Argonaute precipitation and RNAseq (Ago-RP-Seq) we analyzed RISC bound sRNAs (R-sRNAs) in in vitro models and in the brains of multiple in vivo AD mouse models, aged mice, and AD patients. In in vitro cell line studies we find evidence for a contribution of RNAi to the toxicity by toxic Aβ42 oligomers. In addition, in AD mouse models with neurodegeneration, and in the aging brain R-sRNAs RISC bound sRNAs show a shift to more toxic seeds. In contrast, in cells that survived in post-mortem brains of AD patients and the brains of “SuperAgers”, individuals over age 80 who have superior memory performance, R-sRNAs shift to more nontoxic seeds, supporting a protective function of miRNAs. Our data provide first evidence of a contribution of DISE to the neurotoxicity seen in AD suggesting that increasing the levels of protective miRNAs in the brain or blocking the activity of toxic R-sRNAs could lead to a novel way of treating the disease. Significance Statement This work explores a contribution of Death Induced by Survival gene Elimination (DISE), a powerful cell death mechanism based on RNA interference (RNAi) to the neurotoxicity seen in Alzheimer’s disease (AD) which has solely been attributed to toxic proteins (e.g., the amyloid precursor protein or phosphorylated Tau). We show a significant association between the occurrence of toxic short (s)RNAs bound to the RNA induced silencing complex (RISC, which mediates RNAi) and the neurotoxicity seen in various AD models and patients. In addition, toxic oligomeric fragments of APP induce toxicity in part by increasing RISC bound toxic sRNAs and require the RISC component Ago2. Our work offers an alternative view on the cause of the neurotoxicity seen in neurodegenerative diseases.

[1]  M. Peter,et al.  The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference , 2022, Cell Death & Disease.

[2]  Keun-A Chang,et al.  miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease , 2022, International journal of biological sciences.

[3]  Xue Bai,et al.  MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders , 2022, Frontiers in Molecular Neuroscience.

[4]  F. Schmitt,et al.  Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology. , 2022, Brain : a journal of neurology.

[5]  M. Peter,et al.  Identification of the toxic 6mer seed consensus in human cancer cells , 2020, bioRxiv.

[6]  M. Hafner,et al.  CD95/Fas ligand mRNA is toxic to cells , 2018, bioRxiv.

[7]  M. Peter,et al.  DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases , 2021, Journal of experimental & clinical cancer research : CR.

[8]  B. Tang,et al.  p38 MAPK‐mediated loss of nuclear RNase III enzyme Drosha underlies amyloid beta‐induced neuronal stress in Alzheimer's disease , 2021, Aging cell.

[9]  M. Peter,et al.  SPOROS: A pipeline to analyze DISE/6mer seed toxicity , 2021, bioRxiv.

[10]  D. Matei,et al.  The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer , 2021, Cancer Research.

[11]  M. Taheri,et al.  The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease , 2021, Frontiers in Aging Neuroscience.

[12]  K. Xia,et al.  Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy , 2021, Theranostics.

[13]  Inhan Lee,et al.  tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms. , 2020, Journal of Alzheimer's disease : JAD.

[14]  F. Uchiumi,et al.  Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model. , 2020, Biological & pharmaceutical bulletin.

[15]  M. Peter,et al.  6mer Seed Toxicity in Viral microRNAs , 2019, bioRxiv.

[16]  D. Green,et al.  LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease , 2019, Cell.

[17]  J. Kessler,et al.  Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease , 2019, Annals of neurology.

[18]  J. Power,et al.  Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together , 2019, Front. Neurosci..

[19]  P. Palumaa,et al.  Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells. , 2019, Journal of Alzheimer's disease : JAD.

[20]  F. Gage,et al.  Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. , 2018, Annual review of genetics.

[21]  M. Hafner,et al.  6mer seed toxicity in tumor suppressive microRNAs , 2018, Nature Communications.

[22]  Benedikt Zott,et al.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.

[23]  J. Satoh,et al.  Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models , 2018, PloS one.

[24]  Jing-Min Lu,et al.  MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Michael W. Lutz,et al.  Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework , 2018, Alzheimer's & Dementia.

[26]  James C. Cummings,et al.  Profiling of m6A RNA modifications identified an age‐associated regulation of AGO2 mRNA stability , 2018, Aging cell.

[27]  M. Peter,et al.  Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells , 2018, bioRxiv.

[28]  M. Peter,et al.  DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells. , 2018, Trends in cancer.

[29]  P. Palumaa,et al.  In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells , 2017, PloS one.

[30]  D. Scholtens,et al.  Temporo-cerebellar connectivity underlies timing constraints in audition , 2017, eLife.

[31]  M. Peter,et al.  Induction of DISE in ovarian cancer cells in vivo , 2017, bioRxiv.

[32]  H. Erfle,et al.  Dicer and microRNAs protect adult dopamine neurons , 2017, Cell Death and Disease.

[33]  T. Dawson,et al.  Mitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics. , 2017, Annual review of pharmacology and toxicology.

[34]  H. Mizuguchi,et al.  Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA , 2016, Molecular therapy. Nucleic acids.

[35]  Sashwati Roy miRNA in Macrophage Development and Function. , 2016, Antioxidants & redox signaling.

[36]  V. Kim,et al.  Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis , 2016, Proceedings of the National Academy of Sciences.

[37]  D. Krainc,et al.  α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models , 2016, Proceedings of the National Academy of Sciences.

[38]  Y. Tong,et al.  Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[39]  S. Hammond,et al.  Dysregulated miRNA biogenesis downstream of cellular stress and ALS‐causing mutations: a new mechanism for ALS , 2015, The EMBO journal.

[40]  T. Tuschl,et al.  Biochemical isolation of Argonaute protein complexes by Ago-APP , 2015, Proceedings of the National Academy of Sciences.

[41]  Manzoor Ahmad Sofi,et al.  Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[42]  D. Green,et al.  Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins , 2015, Nature Cell Biology.

[43]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[44]  N. Seyfried,et al.  Stress induces p38 MAPK-mediated phosphorylation and inhibition of Drosha-dependent cell survival. , 2015, Molecular cell.

[45]  Martin Prince,et al.  World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors , 2014 .

[46]  A. Lang,et al.  Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice , 2014, Neuroscience.

[47]  M. Peter,et al.  Death induced by CD95 or CD95 ligand elimination. , 2014, Cell reports.

[48]  B. Cullen,et al.  Differential RISC association of endogenous human microRNAs predicts their inhibitory potential , 2014, Nucleic acids research.

[49]  Mark T. W. Ebbert,et al.  Genetics of Alzheimer's Disease , 2013, BioMed research international.

[50]  Carlo Caltagirone,et al.  Inverse occurrence of cancer and Alzheimer disease , 2013, Neurology.

[51]  T. Südhof,et al.  Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.

[52]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[53]  D. Sosnowska,et al.  Aging‐induced dysregulation of Dicer1‐dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[54]  S. Pradervand,et al.  Comprehensive Expression Analyses of Neural Cell-Type-Specific miRNAs Identify New Determinants of the Specification and Maintenance of Neuronal Phenotypes , 2013, The Journal of Neuroscience.

[55]  Sandra Weintraub,et al.  Youthful Memory Capacity in Old Brains: Anatomic and Genetic Clues from the Northwestern SuperAging Project , 2013, Journal of Cognitive Neuroscience.

[56]  Thomas Tuschl,et al.  Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing. , 2012, Methods.

[57]  C. Kahn,et al.  Role of microRNA processing in adipose tissue in stress defense and longevity. , 2012, Cell metabolism.

[58]  F. Slack,et al.  Novel MicroRNAs Differentially Expressed during Aging in the Mouse Brain , 2012, PloS one.

[59]  I. MacRae,et al.  The Crystal Structure of Human Argonaute2 , 2012, Science.

[60]  Natalie G Ahn,et al.  Quantitative functions of Argonaute proteins in mammalian development. , 2012, Genes & development.

[61]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[62]  S. Diamond,et al.  Small Molecule Inhibition of RISC Loading , 2011, ACS chemical biology.

[63]  F. Marabita,et al.  Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b , 2011, Nature Immunology.

[64]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[65]  George A Calin,et al.  Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing , 2011, Proceedings of the National Academy of Sciences.

[66]  L. Jungbauer,et al.  Preparing synthetic Aβ in different aggregation states. , 2011, Methods in molecular biology.

[67]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[68]  E. Bigio,et al.  Calpain-Mediated Tau Cleavage: A Mechanism Leading to Neurodegeneration Shared by Multiple Tauopathies , 2011, Molecular medicine.

[69]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[70]  M. Valko,et al.  Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.

[71]  C. D. Fowler,et al.  Argonaute 2 in dopamine 2 receptor–expressing neurons regulates cocaine addiction , 2010, The Journal of experimental medicine.

[72]  O. Arancio,et al.  Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. , 2010, Journal of visualized experiments : JoVE.

[73]  C. Tabin,et al.  miRNA malfunction causes spinal motor neuron disease , 2010, Proceedings of the National Academy of Sciences.

[74]  Walter J. Lukiw,et al.  Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.

[75]  T. Tomasi,et al.  Dicer is regulated by cellular stresses and interferons. , 2009, Molecular immunology.

[76]  M. Zavolan,et al.  Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. , 2008, RNA.

[77]  T. Tuschl,et al.  Structure of the guide-strand-containing argonaute silencing complex , 2008, Nature.

[78]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[79]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[80]  Qihong Huang,et al.  MicroRNAs can regulate human APP levels , 2008, Molecular Neurodegeneration.

[81]  Z. Paroo,et al.  A small molecule enhances RNA interference and promotes microRNA processing , 2008, Nature Biotechnology.

[82]  Michael T. McManus,et al.  Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus , 2008, The Journal of Neuroscience.

[83]  E. Izaurralde,et al.  GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay , 2008, Nature Structural &Molecular Biology.

[84]  P. Greengard,et al.  Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.

[85]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[86]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[87]  K. Kosik The neuronal microRNA system , 2006, Nature Reviews Neuroscience.

[88]  N. Bonini,et al.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration. , 2006, Molecular cell.

[89]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[90]  Evan Z. Macosko,et al.  Functional and Selective RNA Interference in Developing Axons and Growth Cones , 2006, The Journal of Neuroscience.

[91]  Hirohisa Tajima,et al.  Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. , 2006, Current neuropharmacology.

[92]  Stefan L Ameres,et al.  Cleavage of the siRNA passenger strand during RISC assembly in human cells , 2006, EMBO reports.

[93]  R. Russell,et al.  Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR Evolution , 2005, Cell.

[94]  Qinghua Liu,et al.  Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. , 2005, Genes & development.

[95]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[96]  V. Kim,et al.  The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.

[97]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[98]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[99]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[100]  E. Lai Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.

[101]  M. Vitek,et al.  Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[103]  D. Butterfield,et al.  Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35). , 2001, Journal of the American Chemical Society.

[104]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[105]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[106]  R. Nitsch,et al.  The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress , 2000, The Journal of Neuroscience.

[107]  Yuhui Liu,et al.  Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells , 2000, Journal of neurochemistry.

[108]  S. H. Kim,et al.  Function and dysfunction of the presenilins. , 1999, American journal of human genetics.

[109]  S. Younkin The role of A beta 42 in Alzheimer's disease. , 1998, Journal of physiology, Paris.

[110]  J. de Maeyer-Guignard,et al.  Type I interferons. , 1998, International reviews of immunology.

[111]  T. Holzman,et al.  Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. , 1994, Journal of neuroscience research.

[112]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[113]  D. Kaplan,et al.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.

[114]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[115]  A. Ferreira,et al.  Ganglioside-enhanced neurite growth: evidence for a selective induction of high-molecular-weight MAP-2 , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[116]  B. Peddie,et al.  Enoxacin for the treatment of urinary tract infection. , 1985, The New Zealand medical journal.

[117]  P. Gray,et al.  Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation. , 1977, Nucleic acids research.